FeesSafety
Pluang+

Continuous Ketone Monitoring market to hit $5.48B by 2036, driven by tech advances and diabetes care integration

Market News
20 Nov 2026, 22:54 WIB
Researchandmarkets.Com
View Source
Bullish
Continuous Ketone Monitoring market to hit $5.48B by 2036, driven by tech advances and diabetes care integration

The global Continuous Ketone Monitoring (CKM) market is projected to grow from $118 million in 2026 to $5.48 billion by 2036, at a CAGR of 46.8%. Growth is fueled by rising diabetic ketoacidosis cases, adoption of continuous glucose monitoring, and use of SGLT2 inhibitors. Abbott's Libre Duo systems have led market authorization in the US and Europe, enabling dual glucose-ketone sensing. Future opportunities include integration with automated insulin delivery, hospital monitoring, and expansion in pediatric use. North America leads the market, with Asia-Pacific showing the highest growth potential.

Abbott Laboratories (ABT) leads in health tech with its Libre Duo system, key in the CKM market growth. On Pluang, ABT trades at USD 104.20, up 0.22% as of Nov 20, 2026, 23:12 WIB. The stock's 52-week range is USD 82.57 to 128.90, with a market cap of $179.90B, showing steady investor interest amid expanding ketone monitoring technologies.

More News (ABT)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App